From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Pharmacology (Rated Start-class, Low-importance)
WikiProject icon This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Low  This article has been rated as Low-importance on the project's importance scale.

Page needs wikid amount of cleanup/rewrite. Miserlou 19:43, 7 April 2006 (UTC)

Changed serotonin agonist back to serotonin releaser, because 4MTA is a serotonin releaser, not a serotonin agonist. Research suggests that it releases serotonin both by increasing vesicle trafficking and by reversing the direction of the 5HTT reuptake transporter. Also added onto the stimulants template and removed it from the hallucinogens one, as this compounds profile is more typical of a serotonergic/noradrenergic stimulant, and it is not known for having hallucinogenic effects.

Meodipt 10:50, 30 January 2007 (UTC)

Apparently 4-MTA abuse has lead to deaths - see Nature 469, 7 (2011). (talk) 02:13, 7 July 2011 (UTC)MJP


"but even more dangerous" —Preceding unsigned comment added by (talk) 09:12, 8 June 2008 (UTC)

is that molecule 4-mta, it looks like 4-eta or am i nuts? —Preceding unsigned comment added by (talk) 05:33, 26 October 2008 (UTC)